# OnCo record nct07371663 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07371663/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07371663", "NCT07371663" ;
  schema:name "An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of TCC1727 tablet 90mg in non-small-cell lung cancer, gastric & gastro-oesophageal junction cancer, endometrial cancer and melanoma, run by Beijing Tide Pharmaceutical Co., Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07371663/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07371663> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-12-03" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/benmelstobart/> ;
  onco:companies <https://onco.cc/companies/beijing-tide-pharmaceutical/> .
